Literature DB >> 6407455

Anterior pituitary hormone secretion in chronic schizophrenics.

I N Ferrier, E C Johnstone, T J Crow, I Rincon-Rodriguez.   

Abstract

Venous samples were obtained serially from 18 chronic schizophrenics and nine controls before and after the intravenous administration of protirelin and gonadorelin (gonadotropin releasing hormone [GnRH] ) and by venipuncture from 38 controls. Significant reductions in basal luteinizing hormone (LH) and follicle-stimulating hormone (FSH) were found in the schizophrenic group associated with a reduction in the fluctuation of LH in serial samples. The FSH and prolactin responses to the administration of protirelin and gonadorelin were reduced in the schizophrenic group and abnormal increments of growth hormone secretion were noted in a number of patients, particularly those with reduced basal and stimulated hormone secretion. This pattern of hypothalamic-pituitary dysfunction, which is distinct from that seen in other psychiatric and endocrinological conditions, suggests a reduction in spontaneous GnRH release from the hypothalamus in schizophrenia and may be of potential pathophysiological significance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407455     DOI: 10.1001/archpsyc.1983.01790060053007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  6 in total

Review 1.  Schizophrenia and oestrogens--is there an association?

Authors:  A Riecher-Rössler; H Häfner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

2.  Clinical correlates of postmortem brain changes in schizophrenia: decreased brain weight and length correlate with indices of early impairment.

Authors:  E C Johnstone; C J Bruton; T J Crow; C D Frith; D G Owens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-04       Impact factor: 10.154

3.  Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjects.

Authors:  I Gil-Ad; Z Dickerman; S Amdursky; Z Laron
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Dexamethasone suppression and multiple hormonal responses (TSH, prolactin and growth hormone) to TRH in some psychiatric disorders.

Authors:  C M Banki; M Vojnik; M Arato; Z Papp; Z Kovacs
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

Review 5.  Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia.

Authors:  James S Brown
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

6.  A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human Studies.

Authors:  Eva A Malt; Katalin Juhasz; Ulrik F Malt; Thomas Naumann
Journal:  Front Behav Neurosci       Date:  2016-03-30       Impact factor: 3.558

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.